{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:10:17Z","timestamp":1794485417430,"version":"4.9.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204797\/Z\/16\/Z"],"award-info":[{"award-number":["204797\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206194"],"award-info":[{"award-number":["206194"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206508\/Z\/17\/Z"],"award-info":[{"award-number":["206508\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.isci.2022.105867","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:57:48Z","timestamp":1671796668000},"page":"105867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load"],"prefix":"10.1016","volume":"26","author":[{"given":"Yegnasew","family":"Takele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadele","family":"Mulaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emebet","family":"Adem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Womersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrsini","family":"Kaforou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Ursula","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham Philip","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Anthony","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Kropf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2022.105867_bib1","first-page":"165","article-title":"Global leishmaniasis surveillance, 2017\u20132018, and first report on 5 additional indicators","volume":"25","author":"Ruiz-Postigo","year":"2020","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.isci.2022.105867_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13071-015-0987-y","article-title":"Eco-epidemiology of visceral leishmaniasis in Ethiopia","volume":"8","author":"Gadisa","year":"2015","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.isci.2022.105867_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0163-4453(99)90001-4","article-title":"Visceral leishmaniasis in clinical practice","volume":"39","author":"Davidson","year":"1999","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.isci.2022.105867_bib5","doi-asserted-by":"crossref","first-page":"e0007132","DOI":"10.1371\/journal.pntd.0007132","article-title":"Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia","volume":"13","author":"Diro","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib6","doi-asserted-by":"crossref","first-page":"100583","DOI":"10.1016\/j.curtheres.2020.100583","article-title":"Multiple relapses of visceral leishmaniasis in HIV Co-infected patients: a case series from Ethiopia","volume":"92","author":"Mohammed","year":"2020","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.isci.2022.105867_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2022.105867_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1179\/000349803225002561","article-title":"The pathogenesis of Leishmania\/HIV co-infection: cellular and immunological mechanisms","volume":"97","author":"Olivier","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.isci.2022.105867_bib9","doi-asserted-by":"crossref","first-page":"e2875","DOI":"10.1371\/journal.pntd.0002875","article-title":"High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia","volume":"8","author":"Diro","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-3156.2010.02550.x","article-title":"Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia","volume":"15","author":"Hurissa","year":"2010","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.isci.2022.105867_bib11","doi-asserted-by":"crossref","first-page":"100487","DOI":"10.1016\/j.xcrm.2021.100487","article-title":"Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV","volume":"3","author":"Takele","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2022.105867_bib12","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"Cota","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1590\/S0074-02762010000500016","article-title":"HIV\/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil","volume":"105","author":"Alexandrino-de-Oliveira","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.isci.2022.105867_bib14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"ter Horst","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2334-13-331","article-title":"High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis","volume":"13","author":"de Oliveira","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fcimb.2018.00428","article-title":"Serum levels of soluble CD40 ligand and neopterin in HIV coinfected asymptomatic and symptomatic visceral leishmaniasis patients","volume":"8","author":"Adriaensen","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2022.105867_bib17","doi-asserted-by":"crossref","first-page":"e3132","DOI":"10.1371\/journal.pntd.0003132","article-title":"Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells?","volume":"8","author":"Van den Bergh","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib18","doi-asserted-by":"crossref","first-page":"e1977","DOI":"10.1371\/journal.pntd.0001977","article-title":"Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection","volume":"7","author":"Takele","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib19","doi-asserted-by":"crossref","first-page":"102748","DOI":"10.1016\/j.ebiom.2020.102748","article-title":"Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV","volume":"55","author":"Adriaensen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2022.105867_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1471-2334-10-358","article-title":"High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load","volume":"10","author":"Santos-Oliveira","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/infdis\/jit135","article-title":"Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection","volume":"208","author":"Santos-Oliveira","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib22","doi-asserted-by":"crossref","first-page":"e2134","DOI":"10.1371\/journal.pntd.0002134","article-title":"Arginase: a marker of disease status in patients with visceral leishmaniasis","volume":"7","author":"Abebe","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.actatropica.2017.05.011","article-title":"Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: circulating Leishmania DNA","volume":"172","author":"Cota","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.isci.2022.105867_bib24","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cid\/cix607","article-title":"The risk and predictors of visceral leishmaniasis relapse in human immunodeficiency virus-coinfected patients in Ethiopia: a retrospective cohort study","volume":"65","author":"Abongomera","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib25","doi-asserted-by":"crossref","first-page":"e0167512","DOI":"10.1371\/journal.pone.0167512","article-title":"Immune activation and bacterial translocation: a link between impaired immune recovery and frequent visceral leishmaniasis relapses in HIV-infected patients","volume":"11","author":"Silva-Freitas","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2022.105867_bib26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3389\/fimmu.2020.00953","article-title":"Impaired thymic output can Be related to the low immune reconstitution and T\u00a0cell repertoire disturbances in relapsing visceral leishmaniasis associated HIV\/AIDS patients","volume":"11","author":"Silva-Freitas","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2022.105867_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/hiv.12206","article-title":"Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients","volume":"16","author":"Casado","year":"2015","journal-title":"HIV Med."},{"key":"10.1016\/j.isci.2022.105867_bib28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2471\/BLT.20.255703","article-title":"Transitions between body mass index categories, South Africa","volume":"98","author":"Wandai","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.isci.2022.105867_bib29","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1371\/journal.pmed.0040115","article-title":"Malnutrition and infection: complex mechanisms and global impacts","volume":"4","author":"Schaible","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.isci.2022.105867_bib30","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1753-4887.1998.tb01649.x","article-title":"Protein, calories, and immune defenses","volume":"56","author":"Woodward","year":"1998","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.isci.2022.105867_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fimmu.2016.00153","article-title":"The contribution of immune evasive mechanisms to parasite persistence in visceral leishmaniasis","volume":"7","author":"de Freitas","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2022.105867_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fcimb.2020.00060","article-title":"Hematopoietic stem\/progenitor cells and the pathogenesis of HIV\/AIDS","volume":"10","author":"Tsukamoto","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.isci.2022.105867_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fimmu.2016.00364","article-title":"Impact of viral infections on hematopoiesis: from beneficial to detrimental effects on bone marrow output","volume":"7","author":"Pascutti","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2022.105867_bib34","doi-asserted-by":"crossref","first-page":"e3198","DOI":"10.1371\/journal.pntd.0003198","article-title":"Leishmania specific CD4 T\u00a0cells release IFNgamma that limits parasite replication in patients with visceral leishmaniasis","volume":"8","author":"Kumar","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2334-6-59","article-title":"CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa","volume":"6","author":"Lawn","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib36","doi-asserted-by":"crossref","first-page":"e0240880","DOI":"10.1371\/journal.pone.0240880","article-title":"Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia","volume":"15","author":"Wolday","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2022.105867_bib37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2022.105867_bib38","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/S2352-3018(20)30231-9","article-title":"End resistance to dolutegravir roll-out","volume":"7","author":"The Lancet","year":"2020","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.isci.2022.105867_bib39","unstructured":"WHO. HIV Drug Resistance Report 2019. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-19.2."},{"key":"10.1016\/j.isci.2022.105867_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12879-018-3176-8","article-title":"Adherence to antiretroviral therapy and associated factors among HIV positive adults attending care and treatment in University of Gondar Referral Hospital, Northwest Ethiopia","volume":"18","author":"Molla","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T\u00a0cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2022.105867_bib42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining 'T cell exhaustion'","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2022.105867_bib43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2022.105867_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","article-title":"The role of PD-1 in acute and chronic infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2022.105867_bib45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/jit401","article-title":"CD8 T\u00a0cell exhaustion in human visceral leishmaniasis","volume":"209","author":"Gautam","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib46","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/CVI.00143-12","article-title":"Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood","volume":"19","author":"Singh","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.isci.2022.105867_bib47","doi-asserted-by":"crossref","first-page":"e0004468","DOI":"10.1371\/journal.pntd.0004468","article-title":"Successful treatment of human visceral leishmaniasis restores antigen-specific IFN-gamma, but not IL-10 production","volume":"10","author":"Adem","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib48","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2666-5247(20)30166-X","article-title":"Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study","volume":"2","author":"Singh","year":"2021","journal-title":"Lancet. Microbe"},{"key":"10.1016\/j.isci.2022.105867_bib49","doi-asserted-by":"crossref","first-page":"e0008253","DOI":"10.1371\/journal.pntd.0008253","article-title":"Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context","volume":"14","author":"Molina","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib50","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/167.Supplement_1.S13","article-title":"The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis","volume":"167","author":"Badaro","year":"1993","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2022.105867_bib51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.1983.32.475","article-title":"Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis","volume":"32","author":"Chulay","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.isci.2022.105867_bib54","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422202140X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422202140X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:24:13Z","timestamp":1787261053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258900422202140X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S258900422202140X"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2022.105867","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2022.105867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"105867"}}